Innovation

Scientific innovation drives progress and curious minds discover new solutions that were once only imagined.

We generate new insights, invest deeply in products and solutions, and collaborate with scientists around the world to make an impact on the biggest eye health needs.

Female doctor in white lab coat looking at a monitor with images
Jump to:
Innovation

Our Scientific Innovations

We are reimagining the scale and impact we can make across a patient’s life to pave the way for a new future of eye health.

A blue light illuminating an adult patient's eye during an eye exam

Insight-Driven Care

We drive innovation in eye health by turning patient insights into advanced products. Our global R&D team ensures patients remain at the center of everything we do.

Female researcher examining a magnified contact lens with a look of curiosity

Curiosity-Driven Discovery

Our R&D team innovates with curiosity, tackling eye health issues like myopia, refractive errors, and cataracts to shape the future of eye care.

Legacy & Future

Legacy & Future

We have a proud legacy of firsts and widely transforming how eyes are corrected and cared for including contact lenses and cataract surgery.

Over the course of 40 years, we have built a strong reputation among eye care professionals and patients. This trust has been earned through our commitment to eye health, continuous innovation, uncompromising quality, safety, and performance.


Our focus remains on addressing the unmet eye health needs across one's lifetime.

We're leading with science and establishing new standards of care in order to:

Provide innovative, evidence-based options for myopia management.

Advance industry leading solutions for vision correction.

Restore high-quality and range of vision for presbyopia and cataract patients.

Myopia Management

A cheerful child riding a bike on a sunny day

We're working to change the course of myopia, a major 21st century eye health threat.1 Over two decades, we've invested in R&D to develop evidence-based strategies and innovative treatments. Our ACUVUE Abiliti™ brand offers a comprehensive myopia management solution.

Contact Lenses

Contact lens resting on a finger

In 1988, we introduced ACUVUE®, the first disposable soft contact lens.2 We've continued innovating with Eye-Inspired designs for natural comfort and clear vision. We produce 5 billion contact lenses yearly, helping millions worldwide.3.

Dry Eye Management

Close-up of a black woman's eyes

We understand the discomfort of dry eye syndrome and are innovating our technology to help. We've developed a fully automated treatment for meibomian gland dysfunction (MGD),4 a key cause of dry eye, and offer various therapies to manage this condition. 5

Laser Vision Correction

Young woman smiling at her reflection in the mirror, radiating confidence and happiness

Our refractive surgery technology was designed to boost surgeon confidence, accuracy, and patient outcomes. Our LASIK services use the latest technology to correct refractive errors, offering a path to better vision with less resilience on glasses or contacts.6,7,8,9

Cataract Surgery and Treatment

Close-up of an aging eye, accompanied by informative text about cataract surgery

We are a leader in ophthalmology with our TECNIS® platform, which revolutionized cataract treatment. For over 20 years, our innovations, like the first aspheric foldable IOL and extended depth of focus lOLs, have advanced eye care. 10,11

Innovation: What Does the Future Hold?

Woman with head covering in machinery

By harnessing the power of the world's largest healthcare organization, we will continue to pioneer the future of vision, set new standards of care for the industry, and apply cutting-edge innovation and science-led solutions to make dependable outcomes possible for our customers and patients. With our heritage of innovation, and passion for collaboration, no one's better equipped to see and shape the future of eye health.

Our Offering

Our Offering

Few things are as important as the ability to see life and the world around us. That is what motivates us to reimagine and deliver an all-encompassing eyecare portfolio to meet the unique needs of every patient. Novel products and services address eye health needs throughout a patient's lifetime.

We strive to create a world where all people enjoy peak sight for a lifetime filled with wonder and wow, meaningful connections, and thrilling adventures. We are a partner for the entire eye health journey: from prevention to diagnosis, treatment and recovery. We offer a spectrum of contact lenses, intraocular lenses, and more. With a pioneering spirit, we are harnessing the power of data, artificial intelligence (Al) and interconnected technology to provide personalized solutions.

Product Highlights

Our Platforms

Offering a broad range of eye health solutions to help improve sight across all ages, throughout every life stage, and in every corner of the globe.

Logo of ACUVUE abiliti

Myopia Management

Logo of ACUVUE

Contact Lenses

Logo of TearScience

Dry Eye Treatment

Logo of Elita and iLASIK

Refractive Surgery

Logo of TECNIS Family of IOLs

IOLs and Impants

Logo of Veritas, CATALYS, and Healon Family of OVDs

Cataract Surgical Equipment

Learn More

  • Visit ACUVUE.com to learn more about contact lenses.
  • Healthcare professionals can visit jnjvisionpro.com for information about our products and services, including important safety information.

References:

  1. Holy C, Kulkarni K, Brennan NA. Predicting Costs and Disability from the Myopia Epidemic - A Worldwide Economic and Social Model. Invest Ophthalmol Vis Sci. 2019:60(9):5466-5466.
  2. ACUVUE®. Website: https://www.acuvue.com/en-us/about/. Accessed November 2024.
  3. Johnson & Johnson Vision Investor Relations 4Q211 Internal Report
  4. Information based on internal competitive data and patent analysis as of June 2018 against TearScience and iLux Systems in the US. See iLux website http://www.tearfilm.com/ilux-device/ and TearCare website https://sightsciences.com/us/products/tear-care/
  5. Lemp MA, Crews LA, Bron AJ, Foulks GN, Sullivan BO. Distribution of aqueous-deficient and evaporative dry eye in a clinic-based patient cohort: a retrospective study. Cornea. 2012 Мay:31(5):472-478.
  6. ASCRS 2022 LASIK Flap Accuracy Comparison Between A New Femtosecond Laser and iFS, Mahipal Sachdev
  7. DOF20230TH4002: The ELITA™ Femtosecond Platform Patient Interface Design
  8. DOF2023RF4002: The ELITA™ Femtosecond Laser device description
  9. 0155-1910 ELITA operator's manual (Flap) US edition (v0.2) REF2023RF4014
  10. Fine IH, Hoffman RS. The AMO array foldable silicone multifocal intracular lens. Int Ophthalmol Clin. 2000 Summer:40(3):245-52. (REF20190TH4475)
  11. Johnson &Johnson Vision (2020) TECNIS EyhanceT" IOL with TECNIS Simplicity™ Delivery System. Directions for Use. Document No. Z311524E Rev. A. Revision Date: 1/2021 (REF2021CT4019)
  12. Johnson & Johnson Announces Plans to Accelerate Innovation, Serve Patients and Consumers, and Unlock Value through Intent to Separate Consumer Health Business. JNJ.com. (2021). https://www.jnj.com/media-center/press-releases/johnson-johnson-announces-plans-to-accelerate-innovation-serve-patients-and-consumers-and-unlock-value-through-intent-to-separate-consumer-health-business
Clear Vision For You
About
Help & Customer Care
Vision At Every Stage
Legal
Not actual patients or healthcare professionals. For illustrative purposes only.

Unless otherwise specified, all product names appearing in this Internet site are trademarks owned by or licensed to Johnson & Johnson Vision, Inc., its subsidiaries or affiliates.

No use of any Johnson & Johnson Vision, Inc. trademark, trade name, or trade dress in this site may be made without the prior written authorization of Johnson & Johnson Vision, Inc., except to identify the product or services of the company. Third party trademarks are the property of their respective owners.

This website and the information contained herein is intended for use by US residents only.

© Johnson & Johnson and its affiliates 2024